PRG2
Bone marrow proteoglycan
Also known as: BMPG, MBP, PRG2_HUMAN, proMBP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13727
- Gene
- PRG2
- Ensembl
- ENSG00000186652
- Chromosome
- 11
- Canonical length
- 222 aa
- Protein class
- FDA approved drug targets, Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted in female reproductive system
OverviewNCBI Gene
The protein encoded by this gene is the predominant constituent of the crystalline core of the eosinophil granule. High levels of the proform of this protein are also present in placenta and pregnancy serum, where it exists as a complex with several other proteins including pregnancy-associated plasma protein A (PAPPA), angiotensinogen (AGT), and C3dg. This protein may be involved in antiparasitic defense mechanisms as a cytotoxin and helminthotoxin, and in immune hypersensitivity reactions. The encoded protein contains a peptide that displays potent antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria, and fungi. It is directly implicated in epithelial cell damage, exfoliation, and bronchospasm in allergic diseases. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2014]
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>P13727|PRG2
1 MKLPLLLALL FGAVSALHLR SETSTFETPL GAKTLPEDEE TPEQEMEETP CRELEEEEEW
61 GSGSEDASKK DGAVESISVP DMVDKNLTCP EEEDTVKVVG IPGCQTCRYL LVRSLQTFSQ
121 AWFTCRRCYR GNLVSIHNFN INYRIQCSVS ALNQGQVWIG GRITGSGRCR RFQWVDGSRW
181 NFAYWAAHQP WSRGGHCVAL CTRGGHWRRA HCLRRLPFIC SYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 2,458 nTPM
Expression across tissuesHPA
Tissue
- placenta: 2,458 nTPM
- bone marrow: 203 nTPM
- thymus: 8.1 nTPM
- pancreas: 3.6 nTPM
- spleen: 3 nTPM
- liver: 2.4 nTPM
Single-cell type
- extravillous trophoblasts: 126 nCPM
- monocyte progenitors: 3.2 nCPM
- syncytiotrophoblasts: 2.8 nCPM
- decidual stromal cells: 2.6 nCPM
- migrating cytotrophoblasts: 2.1 nCPM
- mast cells: 1.9 nCPM
Immune cell
- basophil: 7.3 nTPM
- eosinophil: 0.2 nTPM
- total PBMC: 0.1 nTPM
- classical monocyte: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 0.3 nTPM
- pons: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- choroid plexus: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.31
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to bacterium
- defense response to nematode
- immune response
- negative regulation of interleukin-10 production
- negative regulation of macrophage cytokine production
- positive regulation of interleukin-4 production
Molecular functions
- carbohydrate binding
- extracellular matrix structural constituent conferring compression resistance
- heparin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRG2 as an antibody target. Whether an autoantibody or antibody against PRG2 could matter depends on whether native PRG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRG2 is annotated as secreted, so native PRG2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PRG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...